Literature DB >> 15173039

Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.

Michel Azizi1, Joël Ménard.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15173039     DOI: 10.1161/01.CIR.0000131449.94713.AD

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  41 in total

Review 1.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

2.  Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects.

Authors:  Sujata Vaidyanathan; Joanne Jermany; Chingming Yeh; Marie-Noelle Bizot; Riccardo Camisasca
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

3.  Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?

Authors:  Uta C Hoppe
Journal:  Clin Res Cardiol       Date:  2007-02-15       Impact factor: 5.460

Review 4.  Direct renin inhibition: an analysis of possible benefits.

Authors:  Brian K Dockery; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

5.  Nitric oxide inhibits the expression of AT1 receptors in neurons.

Authors:  Neeru M Sharma; Hong Zheng; Yi-Fan Li; Kaushik P Patel
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-04       Impact factor: 4.249

6.  Overview of resistant hypertension: A glimpse of the cardiologist's current standpoint.

Authors:  Luis Paiva; Maria Carmo Cachulo; Rui Providencia; Sergio Barra; Paulo Dinis; Antonio Leitao-Marques
Journal:  World J Cardiol       Date:  2012-09-26

Review 7.  Application of direct renin inhibition to chronic kidney disease.

Authors:  Christian W Mende
Journal:  Cardiovasc Drugs Ther       Date:  2010-04       Impact factor: 3.727

8.  Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.

Authors:  Jaclyn H Neo; Eleanor I Ager; Peter W Angus; Jin Zhu; Chandana B Herath; Christopher Christophi
Journal:  BMC Cancer       Date:  2010-04-10       Impact factor: 4.430

9.  Combination therapy in hypertension: An update.

Authors:  Sanjay Kalra; Bharti Kalra; Navneet Agrawal
Journal:  Diabetol Metab Syndr       Date:  2010-06-24       Impact factor: 3.320

Review 10.  ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Authors:  A C Simões e Silva; K D Silveira; A J Ferreira; M M Teixeira
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.